|
Panacea Biotec Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
2383.88 Cr.
|
P/BV
|
2.85
|
Book Value (Rs.)
|
136.66
|
|
52 Week High/Low (Rs.)
|
647/292
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 639.77 | 492.60 | 551.93 | 456.92 | 659.22 |
| Other Operating Revenues | 0.00 | 66.49 | 7.24 | 3.03 | 2.01 |
| Total Operating Revenues | 639.77 | 559.09 | 559.17 | 459.95 | 661.23 |
| | | | | | |
| Other Income | 16.90 | 20.66 | 25.80 | 51.66 | 10.97 |
| Total Revenue | 656.67 | 579.75 | 584.96 | 511.61 | 672.20 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 290.24 | 214.07 | 210.46 | 211.03 | 281.25 |
| Purchase Of Stock-In Trade | 8.97 | 7.60 | 1.80 | 7.26 | 29.93 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -18.73 | -22.13 | 17.86 | 34.37 | -48.97 |
| Employee Benefit Expenses | 180.78 | 173.05 | 149.57 | 126.48 | 182.94 |
| Finance Costs | 6.05 | 3.88 | 3.58 | 4.44 | 180.84 |
| Depreciation And Amortisation Expenses | 33.06 | 34.81 | 36.71 | 39.12 | 43.66 |
| Other Expenses | 183.17 | 212.42 | 199.54 | 178.76 | 229.95 |
| Total Expenses | 683.54 | 623.70 | 619.52 | 601.47 | 899.60 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -26.87 | -43.94 | -34.56 | -89.86 | -227.40 |
| | | | | | |
| Exceptional Items | 19.50 | 35.99 | 36.03 | 102.66 | 1676.21 |
| Profit/Loss Before Tax | -7.37 | -7.95 | 1.48 | 12.81 | 1448.81 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | -0.21 | 0.01 | 0.69 | 2.56 | 400.73 |
| Deferred Tax | 0.00 | 0.76 | 2.29 | 43.99 | -29.82 |
| Total Tax Expenses | -0.21 | 0.77 | 2.98 | 46.55 | 370.91 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -7.16 | -8.72 | -1.51 | -33.75 | 1077.90 |
| | | | | | |
| Profit/Loss From Continuing Operations | -7.16 | -8.72 | -1.51 | -33.75 | 1077.90 |
| | | | | | |
| Profit/Loss For The Period | -7.16 | -8.72 | -1.51 | -33.75 | 1077.90 |
| | | | | | |
| Minority Interest | 1.79 | 0.35 | 0.33 | 0.51 | -0.02 |
| Consolidated Profit/Loss After MI And Associates | -5.37 | -8.37 | -1.17 | -33.24 | 1077.89 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -0.88 | -1.37 | -0.19 | -5.43 | 175.98 |
| Diluted EPS (Rs.) | -0.88 | -1.37 | -0.19 | -5.43 | 175.98 |
